{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:58:10Z","timestamp":1760385490299},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This study was funded by a grant from the Research Program of the Beijing Pharmaceutical Association"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153927","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T20:02:30Z","timestamp":1461096150000},"page":"e0153927","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study"],"prefix":"10.1371","volume":"11","author":[{"given":"Aiping","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meili","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"issue":"47","key":"ref1","doi-asserted-by":"crossref","first-page":"e2136","DOI":"10.1097\/MD.0000000000002136","article-title":"Epidemiology and Outcome of Severe Sepsis and Septic Shock in Surgical Intensive Care Units in Northern Taiwan","volume":"94","author":"CT Huang","year":"2015","journal-title":"Medicine"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"e107181","DOI":"10.1371\/journal.pone.0107181","article-title":"Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China","volume":"9","author":"J Zhou","year":"2014","journal-title":"PloS one"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jiac.2013.07.006","article-title":"Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study","volume":"20","author":"H Ogura","year":"2014","journal-title":"Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PCC.0b013e31823c980f","article-title":"Epidemiology of sepsis in pediatric intensive care units: first Colombian multicenter study","volume":"13","author":"JC Jaramillo-Bustamante","year":"2012","journal-title":"Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies"},{"issue":"21","key":"ref5","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"JL Vincent","year":"2009","journal-title":"Jama"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"JL Vincent","year":"2006","journal-title":"Critical care medicine"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jac\/dkl354","article-title":"Two decades of imipenem therapy","volume":"58","author":"AC Rodloff","year":"2006","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/dku351","article-title":"beta-Lactam\/beta-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"S Shiber","year":"2015","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"J Garnacho-Montero","year":"2003","journal-title":"Critical care medicine"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-015-1000-z","article-title":"Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality","volume":"19","author":"J Garnacho-Montero","year":"2015","journal-title":"Critical care"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"S Harbarth","year":"2003","journal-title":"The American journal of medicine"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"EH Ibrahim","year":"2000","journal-title":"Chest"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"MH Kollef","year":"1999","journal-title":"Chest"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/cc13938","article-title":"Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy","volume":"18","author":"M Ulldemolins","year":"2014","journal-title":"Critical care (London, England)"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.11-1671","article-title":"Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations","volume":"142","author":"AA Udy","year":"2012","journal-title":"Chest"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"JA Roberts","year":"2009","journal-title":"Critical care medicine"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s001340000741","article-title":"Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing","volume":"27","author":"J Lipman","year":"2001","journal-title":"Intensive care medicine"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003246-200102000-00030","article-title":"Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock","volume":"29","author":"C Joukhadar","year":"2001","journal-title":"Critical care medicine"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"JA Roberts","year":"2012","journal-title":"British journal of clinical pharmacology"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept","volume":"36","author":"JA Roberts","year":"2010","journal-title":"International journal of antimicrobial agents"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijantimicag.2012.10.002","article-title":"beta-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia","volume":"41","author":"Y Hayashi","year":"2013","journal-title":"International journal of antimicrobial agents"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijantimicag.2010.01.022","article-title":"Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?","volume":"35","author":"JA Roberts","year":"2010","journal-title":"International journal of antimicrobial agents"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/0970-9185.98357","article-title":"Renal replacement therapy in ICU","volume":"28","author":"C Deepa","year":"2012","journal-title":"Journal of anaesthesiology, clinical pharmacology"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/00003088-200746120-00003","article-title":"Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy","volume":"46","author":"F Pea","year":"2007","journal-title":"Clinical pharmacokinetics"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/tcrm.1.2.141.62908","article-title":"Renal replacement therapy in the intensive care unit","volume":"1","author":"N Pannu","year":"2005","journal-title":"Therapeutics and clinical risk management"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcrc.2013.05.018","article-title":"Practical considerations for the dosing and adjustment of continuous renal replacement therapy in the intensive care unit","volume":"28","author":"SM Galvagno Jr.","year":"2013","journal-title":"Journal of critical care"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1592\/phco.29.5.562","article-title":"Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis","volume":"29","author":"BH Heintz","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0091270004269796","article-title":"Influence of renal function on the pharmacokinetics of piperacillin\/tazobactam in intensive care unit patients during continuous venovenous hemofiltration","volume":"45","author":"A Arzuaga","year":"2005","journal-title":"Journal of clinical pharmacology"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0009-9236(99)70121-9","article-title":"Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration","volume":"65","author":"I Tegeder","year":"1999","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.41.12.2640","article-title":"Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration","volume":"41","author":"I Tegeder","year":"1997","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003088-200039040-00003","article-title":"Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy","volume":"39","author":"F Thalhammer","year":"2000","journal-title":"Clinical pharmacokinetics"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/cc13939","article-title":"Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines","volume":"18","author":"JA Roberts","year":"2014","journal-title":"Critical care"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.surg.2015.05.018","article-title":"Impact of minimizing diagnostic blood loss in the critically ill","volume":"158","author":"HS Dolman","year":"2015","journal-title":"Surgery"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/AAC.00548-10","article-title":"Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis","volume":"55","author":"MJ Connor Jr.","year":"2011","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1128\/AAC.49.6.2421-2428.2005","article-title":"Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients","volume":"49","author":"DN Fish","year":"2005","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jps.2600790816","article-title":"Stability and kinetics of degradation of imipenem in aqueous solution","volume":"79","author":"GB Smith","year":"1990","journal-title":"Journal of pharmaceutical sciences"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jchromb.2008.09.020","article-title":"Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection","volume":"875","author":"T Legrand","year":"2008","journal-title":"Journal of chromatography B, Analytical technologies in the biomedical and life sciences"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.26.1.78","article-title":"Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography","volume":"26","author":"CM Myers","year":"1984","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jchromb.2007.10.041","article-title":"Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography","volume":"860","author":"KJ Lopez","year":"2007","journal-title":"Journal of chromatography B, Analytical technologies in the biomedical and life sciences"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jpba.2006.11.040","article-title":"LC\/ESI-MS method for the determination of trimetazidine in human plasma: application to a bioequivalence study on Chinese volunteers","volume":"43","author":"Y Jiao","year":"2007","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2110-5820-2-35","article-title":"Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring?","volume":"2","author":"FB Sime","year":"2012","journal-title":"A Systematic Review. Annals of intensive care"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"WA Craig","year":"1998","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"WA Craig","year":"2003","journal-title":"Infectious disease clinics of North America"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1440-1681.2012.05715.x","article-title":"beta-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review","volume":"39","author":"MG Sinnollareddy","year":"2012","journal-title":"Clinical and experimental pharmacology & physiology"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1128\/AAC.01758-10","article-title":"Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration","volume":"55","author":"T Yamamoto","year":"2011","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00134-006-0397-x","article-title":"Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing","volume":"32","author":"CS Bouman","year":"2006","journal-title":"Intensive care medicine"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00003088-200039030-00002","article-title":"Comparative pharmacokinetics of the carbapenems: clinical implications","volume":"39","author":"JW Mouton","year":"2000","journal-title":"Clinical pharmacokinetics"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"M Ulldemolins","year":"2011","journal-title":"Clinical pharmacokinetics"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425255.2010.506187","article-title":"Pharmacokinetic evaluation of piperacillin-tazobactam","volume":"6","author":"Y Hayashi","year":"2010","journal-title":"Expert opinion on drug metabolism & toxicology"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/AAC.00858-07","article-title":"Adsorption of amikacin, a significant mechanism of elimination by hemofiltration","volume":"52","author":"Q Tian","year":"2008","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000324191","article-title":"Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy","volume":"32","author":"DA Pasko","year":"2011","journal-title":"Blood purification"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ki.1995.317","article-title":"Plasma protein adsorption to highly permeable hemodialysis membranes","volume":"48","author":"WR Clark","year":"1995","journal-title":"Kidney international"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1440-1797.2006.00581.x","article-title":"Current status of dosing and quantification of acute renal replacement therapy. Part 2: dosing paradigms and clinical implementation","volume":"11","author":"MR Marshall","year":"2006","journal-title":"Nephrology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T21:29:55Z","timestamp":1567805395000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153927"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Paulus","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153927","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}